Skip to main content
Clinical Trials/NCT03266679
NCT03266679
Completed
Not Applicable

Bipolar Mood Disorders: A Recovery-Oriented Intervention Approach Addressing Deficits In Metacognitive Capacities

Queensland University of Technology2 sites in 1 country4 target enrollmentJuly 26, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metacognitive Capacities
Sponsor
Queensland University of Technology
Enrollment
4
Locations
2
Primary Endpoint
The Indiana Psychiatric Illness Interview (IPII)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The aim of this study is to trial an intervention targeting potential deficits in an individual's ability to form, and reflect upon, ideas about themselves and others (known as metacognitive capacities), specifically in relation to individuals diagnosed with a bipolar mood disorder (BMD).

The proposed research will adopt a mixed qualitative and quantitative design. Participants will be recruited through hospital outpatient groups (i.e., Metro South Addiction & Mental Health Services Woolloongabba Community Health Centre & Beenleigh Community Health Centre in Brisbane, Queensland), and, as necessary, local non government organisations (NGOs), psychiatrists, general practitioners, online support networks (SANE Australia, Black Dog Institute), community mental health services(such as MINDNET), and/or social media groups (Facebook, Twitter) supporting people who meet criteria for a BMD. The research will then use clinical interviews and quantitative (survey) methods to: (1) confirm diagnosis of participants; and (2) confirm deficits in metacognitive capacities of participants. Following this, the research will then involve the implementation of an adapted intervention across a course of 12 months, aimed at improving the metacognitive capacities of participants with a diagnosis of a BMD.

The research will provide an enriched understanding of a dimension of people with BMDs that has not been previously explored. The research will help with gaining an understanding of the metacognitive processes of people with BMDs, and inform more targeted psychological interventions.

Registry
clinicaltrials.gov
Start Date
July 26, 2017
End Date
July 1, 2019
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Priyanka Komandur

PhD Student/Clinical Psychology Registrar

Queensland University of Technology

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with a Bipolar Affective (mood) Disorder
  • Medication has not been changed for at least the past one month
  • No hospitalisations in the past month
  • Able to provide informed consent

Exclusion Criteria

  • Diagnosed with an Intellectual Disability
  • Diagnosed with Schizoaffective Disorder
  • High risk of suicide; defined as current, daily suicidal ideation, or the presence of a current plan and intent to commit suicide

Outcomes

Primary Outcomes

The Indiana Psychiatric Illness Interview (IPII)

Time Frame: IPII + MAS-A (see below) combined take approximately 45- 60 minutes

The IPII is a semi-structured interview that will be used to assess how participants understand their experience with mental illness (i.e., to elicit and assess an illness narrative). The interview is conceptually divided into five sections. First, rapport is established and participants are asked to tell the story of their lives, beginning with their earliest memory. Second, participants are asked if they think they have a mental illness and, if so, whether or not this condition has affected different facets of their life. Third, participants are asked if and how their condition controls their life and, alternately, how they control their condition. Fourth, they are asked how their condition affects, and is affected by others. Finally, participants are asked about their expectations for the future. The narratives of self and illness are then qualitatively analysed (form and quality rather than content) and then quantitatively rated.

The Metacognition Assessment Scale - Abbreviated (MAS-A)

Time Frame: IPII + MAS-A combined take approximately 45-60 minutes

The MAS-A is an observer rating scale that will be used to assess metacognitive capacity. The MAS-A can be used either in a structured interview format or during a therapy session. The measure presumes that metacognition is comprised of multiple related but semi-independent functions. The MAS-A provides an overall measure of metacognitive capacity, as well as four subscale measures. The four subscales are: 1) Self-reflectivity or Understanding of One's Own Mind - the ability of a person to think about his or her own mental states; 2) Understanding Others' Minds - the ability to think about the mental states of others; 3) Decentration - the ability to see other's mental states with motivations and hypotheses independent from their own); and, 4) Mastery - the ability to use

The Narrative Coherence Rating Scale (NCRS)

Time Frame: 10-15 minutes

The NCRS is a six item, 18-point rating scale developed to assess narrative coherence of illness narratives elicited from the IPII. The six items are: 1) "Logical connections" among the narrative of past psychiatric illnesses; 2) "Logical connections" among the narrative of psychiatric illnesses in the present; 3) "Richness of historical detail" among the narrative of past psychiatric illnesses; 4) "Richness of historical detail" among the narrative of psychiatric illnesses in the present; 5) "Plausibility" among the narrative of psychiatric illnesses in the past; and 6) "Plausibility" among the narrative of psychiatric illnesses in the present. A trained rater reviews an IPII transcript and rates according to scoring anchors (Lysaker et al., 2002).

Secondary Outcomes

  • The Young Mania Rating Scale (YMRS)(10 minutes)
  • The Sheehan Disability Scale (SDS)(1-2 minutes)
  • The 36-Item Short Form Healthy Survey (SF-36)(5-10 minutes)
  • The Hamilton Depression Rating Scale (HDRS)(10 minutes)
  • The Inventory of Interpersonal Difficulties (IIP-32)(5 minutes)
  • Treatment Outcome Package (TOP)(15-20 minutes)

Study Sites (2)

Loading locations...

Similar Trials